A B S T R A C T Sertum IgE
A B S T R A C T Sertum IgE concentrations were determined and IgE turnover studies were performed in control individtuals as well as in patients with several disease states. Patients with common variable hypogammaglobulinemia, thymoma and hypogammaglobulinemia, ataxia telangiectasia, and selective IgA deficiency had significantly decreased mean serum IgE concentrations. In turnover stuldies, this was found to be due to decreased IgE synthesis. In spite of these depressed mean values, some patients with common variable hypogammaglobtulinemia had normal sertum IgE concentrations and synthetic rates.
Patients with the Wiskott-Aldrich syndrome had a significantly elevated mean serum IgE concentration. In one of four patients studied with the turnover technique, a strikingly high IgE concentration was present and was associated with an elevated IgE synthetic rate. Three other patients had both normal sertum IgE concentrations and synthetic rates.
Patients with chronic lymphocytic leukemia had significantly decreased mean serum concentrations and synthetic rates for IgE. The depressed IgE synthesis was associated with a significantly prolonged IgE half-life.
Patients with Hodgkin's disease had significantly increased serum IgE concentrations. One of three patients studied had a high serum IgE concentration and synthetic rate of IgE. The two other patients had normal serum IgE concentrations associated with normal synthetic rates.
Finally, patients with protein-losing enteropathy or familial hypercatabolic hypoproteinemia had normal IgE concentrations associated with normal IgE metabolic parameters. In these cases, the disorder INTRODUCTION In 1966 Ishizaka and co-workers demonstrated that human reaginic antibody is associated with a distinct class of immtunoglobulin, subsequently designated IgE (1) . Independently, Johansson and Bennich described a myeloma protein (ND)' that was antigenically identical to IgE (2); later, a second IgE myeloma protein (PS) was detected by Ogawa and co-workers (3) .
The isolation of these myeloma proteins permitted the definition of the chemical characteristics of IgE molecules and the development of a variety of radioimmunoassays forthe quantitation ofserum IgE levels.
The serum concentration of any plasma protein, including IgE, is determined by its rate of synthesis and rate of catabolism as well as its distribution pattern. Pathologic processes affect these metabolic parameters in characteristic ways and this gives rise in tum to characteristic alterations in serum protein levels. Metabolic turnover studies with purified radioiodinated proteins of four of the major classes of immunoglobulin molecules (IgG, IgA, IgM, and IgD) have allowed the definition of the metabolic characteristics of these immunoglobulin classes and have led to the identification of disorders of these metabolic parameters in disease (4, 5) .
In the present paper we report on the metabolic 'ND and PS refer to the IgE proteins used in the turnover study and their souirce in this paper. Control patients in the IgE metabolic turnover studies consisted of 10 patients with neuromuscular or neoplastic diseases who were suitable for study because they had normal serum IgE concentrations and because groups of patients with comparable disorders had normal serum IgE levels. These patients included one patient with malignant melanoma, one patient with the adult Fanconi syndrome, and eight patients with various neuromuscular disorders. Their ages ranged from 11 to 63 yr; seven were male and three were female. None of the patients in these groups had a history of allergic disorders, skin conditions, or evidence of parasitic infestation.
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Serum IgE levels were determined on larger groups of patients with these different clinical states (Table I) . Pertinent clinical data concerning these patients are listed in Tables II-VI. All patients and controls gave informed consent to the performance of the turnover studies.
Preparation of labeled IgE. Plasma from a patient (PS) with IgE myeloma given to us by Dr. 0. R. McIntyre (Department of Medicine, Dartmouth Medical School, Hanover, N. H.) served as the source of purified IgE in the majority of turnover studies. The plasma was dialyzed against 0.01 M Tris, pH 8.0,0.02 M NaCl buffer, and applied to a DEAE cellulose column equilibrated with the same buffer. (Whatman Inc., Clifton, N. J.) The column was then eluted with the starting buffer to obtain a broad protein peak and then eluted with 0.01 M Tris, pH 8.0, 0.06 M NaCl buffer to obtain a second protein peak; this peak consisted of pure IgE as shown in Ouchterlony double diffusion analysis by using goat antisera to human IgE, IgG, IgA, IgM, albumin transferrin, and whole serum (Melroy Laboratories, Springfield, Va.). A number of studies were also performed with an IgE preparation purified from the serum of patient ND by Drs. Johansson Protocol ofturnover study. All patients were hospitalized on the wards of the Clinical Center of the National Institutes of Health during the period of study. Over this period they were clinically stable and their serum IgE concentration remained constant. Therefore, the patients were considered to be in a steady state with regard to IgE metabolism. They received five drops of saturated potassium iodide solution three times a day during the study to prevent thyroidal uptake of radioiodine. The study was begun by administration of uCi of labeled IgE intravenously from a calibrated syringe. Serum samples were collected at 10 min, at 4 h, and daily for 7 to 14 days; complete 24-h urine specimens were collected each 24 h. Serum and urine samples as well as a measured dilution of the administered dose were counted with a gamma ray well-type scintillation counter with a thallium-activated sodium iodide crystal.
Serum IgE concentration was measured by double antibody radioimmunoassay according to the method described previously (7 concentration. These patients also had values for the IgE total circulating pool size and IgE synthetic rates that were within the 90% confidence interval of the normal population. Thus, in these patients, metabolic parameters for IgE were much closer to normal values than corresponding values for other immunoglobulins. In other words, the concentration and metabolism of IgE may be discordant with that of other immunoglobulins in certain patients with hypogammaglobulinemia.
Thymoma and hypogammaglobulinemia. The serum IgE level was markedly depressed in all the patients with thymoma and hypogammaglobulinemia studied. No IgE was detectable in the serum of eight of the nine patients with thymoma and reduction of all other classes of immunoglobulins. In the remaining patient the IgE level was only 8 nglml.
Similarly, no IgE was detectable in the serum of the two patients with thymoma and markedly reduced serum concentrations of IgG and IgA but significantly elevated serum concentrations of IgM. Metabolic turnover studies were performed in three patients with thymoma and hypogammaglobulinemia in whom no serum IgE was detectable (Table II) . In these studies the thymoma patients were found to have significantly increased plasma volumes compared to those of control individuals (mean value of 52.9±+11.5 ml/kg vs. normal mean of 37.9±7.0 ml/kg; P < 0.02) and this was associated with decreased circulating IgE pools. The serum survival ti of IgE was somewhat prolonged to 3.6 days but the fractional catabolic rate was not significantly different from that in control individuals. Finally, the synthetic rate was less than 1/40 of that of control individuals and thus, the strikingly low serum IgE was due to decreased synthesis of IgE and not to excessive catabolism of this immunoglobulin.
Chronic lymphocytic leukemia. In general, the serum levels of IgE were reduced in patients with neoplasms affecting B lymphocytes or plasma cells. Thus, the IgE levels of 32 patients with chronic lymphocytic leukemia were extremely reduced with a geometric mean serum IgE concentration of 18 ng/ml, a value that differed significantly from that of the normal population (P < 0.001). In 63% of the patients with chronic lymphocytic leukemia IgE was below 15 ng/ml, that is, below the 10th percentile for normal
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A. Iio adults. IgE metabolic turnover studies were performed thesis of IgE which was associated with, but not fully on seven of the patients with chronic lymphocytic compensated by, an increase in IgE survival. leukemia (Table III) . The serum IgE concentration of Multiple myeloma and Waldenstrbm's macroglobuthese patients was generally decreased with a geo-linemia. The mean IgE concentration was signifmetric mean of 10.7 ng/ml and a 68% confidence icantly lower than normal (P < 0.05) in patients interval of 3.3-35.4 ng/ml. In these turnover studies, with multiple myeloma associated with an IgG or IgA increased plasma volumes averaging 72.2+±26.4 ml/kg paraprotein. 16 patients with multiple myeloma and an were found; however, total circulating IgE was still IgG paraprotein had a geometric mean serum IgE significantly decreased with a geometric mean of 0.74 concentration of 27 ng/ml and the 17 patients with pug/kg and a 68% interval of 0.25-2.15 pg/kg (P < 0.01). multiple myeloma and IgA paraprotein had a geoOf considerable interest is the fact that this patient metric mean IgE level of 36 ng/ml. 56 patients with group had a significantly prolonged mean serum Waldenstrom's macroglobulinemia had a geometric survival time and decreased fractional catabolic rate: mean IgE level of 67 ng/ml. Although this value is the mean values for these parameters were 3.6+0.9 lower than the control mean, the difference is not days (P < 0.05) and 65±14% (P < 0.02), respectively. significant (P > 0.05). IgE turnover studies were perThe synthetic rate was significantly decreased com-formed in two patients with IgG myeloma, one patient pared to control values with a geometric mean of with IgA myeloma, and two patients with Walden-0.74 ,g/kg per day (P < 0.01). In all, the decreased strom's macroglobulinemia (Table III) . These studies serum IgE resulted from the severely impaired syn-included two patients, one with IgG myeloma and The abnormalities of serum IgE concentration and the underlying alterations in IgE metabolism responsible for the abnormalities in the various diseases reported here are similar, in many cases, to these observed with IgG, IgA, and IgM. In a number of instances, however, IgE concentration and metabolism are discordant with the other immunoglobulins. In part, this is a reflection of the fact that IgE synthetic rates are far lower than those of other immunoglobulin molecules, whereas fractional catabolic rates are far higher. Additionally, the discordance is related to the presence of unique mechanisms operating on IgE synthesis and catabolism, but not on other immunoglobulins.
Metabolic studies have helped establish that a generalized defect of immunoglobulin synthesis underlies the broad category of diseases known as the hypogammaglobulinemias. This category includes patients with severe combined immune deficiency in whom both B-and T-cell abnormalities are present, as well as patients with infantile xlinked agammaglobulinemia in whom a B-cell abnormality is present (11) (12) (13) (14) (15) . In patients with these diseases there is generalized depression of immunoglobulin levels, including (24) . In most patients with thymoma and hypogammaglobulinemia, essentially no IgE was present in the serum and metabolic studies showed that a disorder of IgE synthesis and not catabolism accounted for this IgE concentration defect.
The hypogammaglobulinemia associated with B-cell neoplasms, chronic lymphocytic leukemia, and multiple myeloma may be due, in part, to production by malignant classes of cells of humoral regulators of B-cell proliferation and immunoglobulin synthesis (25, 26) . In the case of myeloma, another potential factor in the impaired synthesis of polyclonal immunoglobulins may be the presence of suppressor mononuclear cells. In this regard we have recently shown that the majority of patients with multiple myeloma had circulating phagocytic mononuclear cells that suppressed polyclonal immunoglobulin synthesis (27) .
These negative pathophysiological mechanisms, whatever their precise role, affect all classes of immunoglobulins, including IgE the normal rate of catabolism is usually low relative to the pathologic rate (6% of the IV pool/day for IgG), and the effect of a pathologic catabolic rate of 30% of the IV pool/day is to lower the serum level to 17% of normal by using the equation shown above. In summary, the groups of patients with hypogammaglobulinemia due to short immunoglobulin survival have normal IgE levels in contrast to the markedly reduced IgE levels in the majority of patients with a generalized defect of immunoglobulin synthesis. Thus, the IgE level may be of value in differentiating patients who have hypogammaglobulinemia due to hypercatabolism from those who have the same abnormalities due to decreased synthesis.
Elevated IgE levels have been noted in patients with parasitic infestations, with skin rashes, and with such allergic disorders as eczema and asthma (33) (34) (35) (36) .
In the present study we examined IgE levels and IgE metabolism in two other groups of patients with elevated IgE levels, those with Hodgkin's disease and those with the Wiskott-Aldrich syndrome. In each of Metabolism of IgE 753 I these disorders the mean IgE level was markedly elevated; however, it should be noted that whereas certain patients had exceedingly high IgE levels, other patients had IgE levels within the normal range. On the basis of the metabolic turnover studies it is clear that increased IgE synthesis was the primary factor in the elevated IgE levels observed in these patients. Both the Wiskott-Aldrich syndrome, a disorder characterized by thrombocytopenia, eczema and an increased incidence of infections, and Hodgkin's disease are complex disorders which can result in high IgE levels on the basis of a number of possible pathophysiologic mechanisms. One possibility has as its basis the fact that both the Wiskott-Aldrich syndrome and Hodgkin's disease are associated with T-cell dysfunction (37, 38) . Tada, Okumura, and co-workers have obtained evidence that thymic-dependent regulatory cells play a major role in terminating IgE antibody responses and thus can limit the synthesis of IgE generally (39, 40 (Fig. 1) between the synthetic rate and the serum IgE concentration (F = 0.98, P < 0.001). Moreover, in contrast to the observations with other immunoglobulin molecules, there were no groups of patients in whom a low IgE level was due to reduced IgE survival or a high IgE level was due to prolonged survival. This is not to say, however, that catabolic factors play no role in the control of IgE levels. We have seen (41) that extremely high IgE levels in patients with a myeloma producing an IgE paraprotein are, in fact, associated with a decreased IgE fractional catabolic rate. Rather, it is more correct to say that at the IgE concentrations seen in most pathologic states, catabolic mechanisms are not saturated and a high catabolic rate is observed, regardless of serum IgE concentration.
